Global Non-ionic Iodine Contrast Media 麻豆原创 Research Report 2023

Publication ID:

PB504231091

Publication Date:

May 12, 2023

Pages:

100

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Highlights
The global Non-ionic Iodine Contrast Media market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Non-ionic Iodine Contrast Media is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Non-ionic Iodine Contrast Media is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Non-ionic Iodine Contrast Media include GE Healthcare, Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma and Sanochemia, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Non-ionic Iodine Contrast Media, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-ionic Iodine Contrast Media.
The Non-ionic Iodine Contrast Media market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Non-ionic Iodine Contrast Media market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-ionic Iodine Contrast Media manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Hengrui Medicine
Lantheus
YRPG
BeiLu Pharma
Sanochemia
Tyco Healthcare
Imax
Grupo Juste
Daiichi Sankyo
Takeda
Fuji Pharma
Towaseiyaku
Hikari Pharmaceutical
Consentis Diagnostics GmbH
T2Pharma
Segment by Type
Iohexol
Iodixanol
Iopamidol
Ioversol
Others
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-ionic Iodine Contrast Media manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-ionic Iodine Contrast Media in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Non-ionic Iodine Contrast Media 麻豆原创 Overview
1.1 Product Overview and Scope of Non-ionic Iodine Contrast Media
1.2 Non-ionic Iodine Contrast Media Segment by Type
1.2.1 Global Non-ionic Iodine Contrast Media 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Iohexol
1.2.3 Iodixanol
1.2.4 Iopamidol
1.2.5 Ioversol
1.2.6 Others
1.3 Non-ionic Iodine Contrast Media Segment by Application
1.3.1 Global Non-ionic Iodine Contrast Media 麻豆原创 Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Non-ionic Iodine Contrast Media 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Non-ionic Iodine Contrast Media Revenue 2018-2029
1.4.2 Global Non-ionic Iodine Contrast Media Sales 2018-2029
1.4.3 Global Non-ionic Iodine Contrast Media 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Non-ionic Iodine Contrast Media 麻豆原创 Competition by Manufacturers
2.1 Global Non-ionic Iodine Contrast Media Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Non-ionic Iodine Contrast Media Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Non-ionic Iodine Contrast Media Average Price by Manufacturers (2018-2023)
2.4 Global Non-ionic Iodine Contrast Media Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Non-ionic Iodine Contrast Media, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-ionic Iodine Contrast Media, Product Type & Application
2.7 Non-ionic Iodine Contrast Media 麻豆原创 Competitive Situation and Trends
2.7.1 Non-ionic Iodine Contrast Media 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-ionic Iodine Contrast Media Players 麻豆原创 Share by Revenue
2.7.3 Global Non-ionic Iodine Contrast Media 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-ionic Iodine Contrast Media Retrospective 麻豆原创 Scenario by Region
3.1 Global Non-ionic Iodine Contrast Media 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Non-ionic Iodine Contrast Media Global Non-ionic Iodine Contrast Media Sales by Region: 2018-2029
3.2.1 Global Non-ionic Iodine Contrast Media Sales by Region: 2018-2023
3.2.2 Global Non-ionic Iodine Contrast Media Sales by Region: 2024-2029
3.3 Global Non-ionic Iodine Contrast Media Global Non-ionic Iodine Contrast Media Revenue by Region: 2018-2029
3.3.1 Global Non-ionic Iodine Contrast Media Revenue by Region: 2018-2023
3.3.2 Global Non-ionic Iodine Contrast Media Revenue by Region: 2024-2029
3.4 North America Non-ionic Iodine Contrast Media 麻豆原创 Facts & Figures by Country
3.4.1 North America Non-ionic Iodine Contrast Media 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Non-ionic Iodine Contrast Media Sales by Country (2018-2029)
3.4.3 North America Non-ionic Iodine Contrast Media Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-ionic Iodine Contrast Media 麻豆原创 Facts & Figures by Country
3.5.1 Europe Non-ionic Iodine Contrast Media 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Non-ionic Iodine Contrast Media Sales by Country (2018-2029)
3.5.3 Europe Non-ionic Iodine Contrast Media Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-ionic Iodine Contrast Media 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Non-ionic Iodine Contrast Media 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Non-ionic Iodine Contrast Media Sales by Country (2018-2029)
3.6.3 Asia Pacific Non-ionic Iodine Contrast Media Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Non-ionic Iodine Contrast Media 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Non-ionic Iodine Contrast Media 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Non-ionic Iodine Contrast Media Sales by Country (2018-2029)
3.7.3 Latin America Non-ionic Iodine Contrast Media Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-ionic Iodine Contrast Media 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Non-ionic Iodine Contrast Media 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Non-ionic Iodine Contrast Media Sales by Country (2018-2029)
3.8.3 Middle East and Africa Non-ionic Iodine Contrast Media Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-ionic Iodine Contrast Media Sales by Type (2018-2029)
4.1.1 Global Non-ionic Iodine Contrast Media Sales by Type (2018-2023)
4.1.2 Global Non-ionic Iodine Contrast Media Sales by Type (2024-2029)
4.1.3 Global Non-ionic Iodine Contrast Media Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Non-ionic Iodine Contrast Media Revenue by Type (2018-2029)
4.2.1 Global Non-ionic Iodine Contrast Media Revenue by Type (2018-2023)
4.2.2 Global Non-ionic Iodine Contrast Media Revenue by Type (2024-2029)
4.2.3 Global Non-ionic Iodine Contrast Media Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Non-ionic Iodine Contrast Media Price by Type (2018-2029)
5 Segment by Application
5.1 Global Non-ionic Iodine Contrast Media Sales by Application (2018-2029)
5.1.1 Global Non-ionic Iodine Contrast Media Sales by Application (2018-2023)
5.1.2 Global Non-ionic Iodine Contrast Media Sales by Application (2024-2029)
5.1.3 Global Non-ionic Iodine Contrast Media Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Non-ionic Iodine Contrast Media Revenue by Application (2018-2029)
5.2.1 Global Non-ionic Iodine Contrast Media Revenue by Application (2018-2023)
5.2.2 Global Non-ionic Iodine Contrast Media Revenue by Application (2024-2029)
5.2.3 Global Non-ionic Iodine Contrast Media Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Non-ionic Iodine Contrast Media Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GE Healthcare Non-ionic Iodine Contrast Media Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bayer Non-ionic Iodine Contrast Media Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Bracco Imaging
6.3.1 Bracco Imaging Corporation Information
6.3.2 Bracco Imaging Description and Business Overview
6.3.3 Bracco Imaging Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bracco Imaging Non-ionic Iodine Contrast Media Product Portfolio
6.3.5 Bracco Imaging Recent Developments/Updates
6.4 Guerbet Group
6.4.1 Guerbet Group Corporation Information
6.4.2 Guerbet Group Description and Business Overview
6.4.3 Guerbet Group Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Guerbet Group Non-ionic Iodine Contrast Media Product Portfolio
6.4.5 Guerbet Group Recent Developments/Updates
6.5 Hengrui Medicine
6.5.1 Hengrui Medicine Corporation Information
6.5.2 Hengrui Medicine Description and Business Overview
6.5.3 Hengrui Medicine Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hengrui Medicine Non-ionic Iodine Contrast Media Product Portfolio
6.5.5 Hengrui Medicine Recent Developments/Updates
6.6 Lantheus
6.6.1 Lantheus Corporation Information
6.6.2 Lantheus Description and Business Overview
6.6.3 Lantheus Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Lantheus Non-ionic Iodine Contrast Media Product Portfolio
6.6.5 Lantheus Recent Developments/Updates
6.7 YRPG
6.6.1 YRPG Corporation Information
6.6.2 YRPG Description and Business Overview
6.6.3 YRPG Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.4.4 YRPG Non-ionic Iodine Contrast Media Product Portfolio
6.7.5 YRPG Recent Developments/Updates
6.8 BeiLu Pharma
6.8.1 BeiLu Pharma Corporation Information
6.8.2 BeiLu Pharma Description and Business Overview
6.8.3 BeiLu Pharma Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.8.4 BeiLu Pharma Non-ionic Iodine Contrast Media Product Portfolio
6.8.5 BeiLu Pharma Recent Developments/Updates
6.9 Sanochemia
6.9.1 Sanochemia Corporation Information
6.9.2 Sanochemia Description and Business Overview
6.9.3 Sanochemia Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sanochemia Non-ionic Iodine Contrast Media Product Portfolio
6.9.5 Sanochemia Recent Developments/Updates
6.10 Tyco Healthcare
6.10.1 Tyco Healthcare Corporation Information
6.10.2 Tyco Healthcare Description and Business Overview
6.10.3 Tyco Healthcare Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Tyco Healthcare Non-ionic Iodine Contrast Media Product Portfolio
6.10.5 Tyco Healthcare Recent Developments/Updates
6.11 Imax
6.11.1 Imax Corporation Information
6.11.2 Imax Non-ionic Iodine Contrast Media Description and Business Overview
6.11.3 Imax Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Imax Non-ionic Iodine Contrast Media Product Portfolio
6.11.5 Imax Recent Developments/Updates
6.12 Grupo Juste
6.12.1 Grupo Juste Corporation Information
6.12.2 Grupo Juste Non-ionic Iodine Contrast Media Description and Business Overview
6.12.3 Grupo Juste Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Grupo Juste Non-ionic Iodine Contrast Media Product Portfolio
6.12.5 Grupo Juste Recent Developments/Updates
6.13 Daiichi Sankyo
6.13.1 Daiichi Sankyo Corporation Information
6.13.2 Daiichi Sankyo Non-ionic Iodine Contrast Media Description and Business Overview
6.13.3 Daiichi Sankyo Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Daiichi Sankyo Non-ionic Iodine Contrast Media Product Portfolio
6.13.5 Daiichi Sankyo Recent Developments/Updates
6.14 Takeda
6.14.1 Takeda Corporation Information
6.14.2 Takeda Non-ionic Iodine Contrast Media Description and Business Overview
6.14.3 Takeda Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Takeda Non-ionic Iodine Contrast Media Product Portfolio
6.14.5 Takeda Recent Developments/Updates
6.15 Fuji Pharma
6.15.1 Fuji Pharma Corporation Information
6.15.2 Fuji Pharma Non-ionic Iodine Contrast Media Description and Business Overview
6.15.3 Fuji Pharma Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Fuji Pharma Non-ionic Iodine Contrast Media Product Portfolio
6.15.5 Fuji Pharma Recent Developments/Updates
6.16 Towaseiyaku
6.16.1 Towaseiyaku Corporation Information
6.16.2 Towaseiyaku Non-ionic Iodine Contrast Media Description and Business Overview
6.16.3 Towaseiyaku Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Towaseiyaku Non-ionic Iodine Contrast Media Product Portfolio
6.16.5 Towaseiyaku Recent Developments/Updates
6.17 Hikari Pharmaceutical
6.17.1 Hikari Pharmaceutical Corporation Information
6.17.2 Hikari Pharmaceutical Non-ionic Iodine Contrast Media Description and Business Overview
6.17.3 Hikari Pharmaceutical Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Hikari Pharmaceutical Non-ionic Iodine Contrast Media Product Portfolio
6.17.5 Hikari Pharmaceutical Recent Developments/Updates
6.18 Consentis Diagnostics GmbH
6.18.1 Consentis Diagnostics GmbH Corporation Information
6.18.2 Consentis Diagnostics GmbH Non-ionic Iodine Contrast Media Description and Business Overview
6.18.3 Consentis Diagnostics GmbH Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Consentis Diagnostics GmbH Non-ionic Iodine Contrast Media Product Portfolio
6.18.5 Consentis Diagnostics GmbH Recent Developments/Updates
6.19 T2Pharma
6.19.1 T2Pharma Corporation Information
6.19.2 T2Pharma Non-ionic Iodine Contrast Media Description and Business Overview
6.19.3 T2Pharma Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.19.4 T2Pharma Non-ionic Iodine Contrast Media Product Portfolio
6.19.5 T2Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-ionic Iodine Contrast Media Industry Chain Analysis
7.2 Non-ionic Iodine Contrast Media Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-ionic Iodine Contrast Media Production Mode & Process
7.4 Non-ionic Iodine Contrast Media Sales and 麻豆原创ing
7.4.1 Non-ionic Iodine Contrast Media Sales Channels
7.4.2 Non-ionic Iodine Contrast Media Distributors
7.5 Non-ionic Iodine Contrast Media Customers
8 Non-ionic Iodine Contrast Media 麻豆原创 Dynamics
8.1 Non-ionic Iodine Contrast Media Industry Trends
8.2 Non-ionic Iodine Contrast Media 麻豆原创 Drivers
8.3 Non-ionic Iodine Contrast Media 麻豆原创 Challenges
8.4 Non-ionic Iodine Contrast Media 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Hengrui Medicine
Lantheus
YRPG
BeiLu Pharma
Sanochemia
Tyco Healthcare
Imax
Grupo Juste
Daiichi Sankyo
Takeda
Fuji Pharma
Towaseiyaku
Hikari Pharmaceutical
Consentis Diagnostics GmbH
T2Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.